Filter News
Area of Research
- (-) Neutron Science (9)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (1)
- Biology and Environment (12)
- Clean Energy (36)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (2)
- Fusion and Fission (10)
- Fusion Energy (2)
- Isotopes (7)
- Materials (29)
- Materials for Computing (3)
- National Security (12)
- Quantum information Science (1)
- Supercomputing (16)
News Type
News Topics
- (-) Advanced Reactors (3)
- (-) Biomedical (5)
- (-) Cybersecurity (2)
- (-) Energy Storage (2)
- (-) Fusion (2)
- (-) Isotopes (2)
- 3-D Printing/Advanced Manufacturing (5)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (4)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (5)
- Decarbonization (2)
- Environment (4)
- Frontier (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (14)
- Microscopy (1)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (43)
- Nuclear Energy (10)
- Physics (7)
- Quantum Science (5)
- Security (1)
- Space Exploration (3)
- Summit (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.